Breaking News: DEA Just Published its Final Rule on EMS Agencies…Here are the Key Takeaways You Need to be Aware of!

By: Hunter DeKoninck

On February 5, 2026, the Drug Enforcement Administration (DEA) published a final rule implementing major changes to how Emergency Medical Services (EMS) agencies are registered under the Controlled Substances Act (CSA) and changes to EMS agencies’ obligations regarding the handling of controlled substances (the “Final Rule”). The Final Rule fulfills statutory requirements of the Protecting Patient Access to Emergency Medications Act of 2017 (the “Act”), aligning DEA’s regulations with congressional intent and bringing clarity to EMS agencies’ regulatory obligations.

So, why is this a big deal? Why is the Final Rule a newsworthy development? Well, historically, EMS agencies and hospital systems have sat frustrated and confused with how EMS agencies should operate because the CSA and DEA’s regulations did not clearly address the unique environment in which the agencies operate (i.e. vehicle-based, mobile-oriented and emergency-driven).  There was much uncertainty in how EMS agencies were expected to obtain and manage DEA registrations for their various vehicles, facilities and stations. There was also great uncertainty and inconsistency in how EMS agencies’ were expected to procure, stock and use controlled substances in the field. However, now, the Final Rule equips the industry with an EMS-specific registration framework that eliminates much of the historical uncertainty and confusion.

The Final Rule makes a significant number of changes to the CFR, including: a new definitions section dedicated to EMS agency-related terms (21 CFR 1300.06); a new section specific to EMS agency registrations (21 CFR 1301.20); a new section that lists security measures specific to EMS agencies (21 CFR 1301.80); a new section with recordkeeping requirements unique to EMS agencies; and a new section that addresses EMS agencies’ delivery of controlled substances to among their various locations (21 CFR 1307.14).

This post will not detail all of the changes that come with the Final Rule, but I do want to take the opportunity to outline the key takeaways that will impact EMS agencies, as well as the hospitals and practitioners that work with them and the wholesalers that supply them.

Key Elements of the Final Rule

✔️ A New Registration Category for EMS Agencies

For the first time, EMS agencies authorized to practice under state law can register directly with DEA under a new category that is specific to EMS agencies. This gives EMS agencies a recognized status separate from other registrant types (such as practitioners or hospitals).

✔️ One Registration Per State, Not Per Station

Previously, EMS providers often needed separate DEA registrations for each physical location or station they used. Under the Final Rule and the new regulatory provision 21 CFR 1301.20(a)(1), EMS agencies are now expressly authorized to only obtain a single registration for the entire state in which it operates, greatly simplifying compliance and reducing redundant paperwork. DEA defines the EMS agency’s “registered location” to mean the location “where the agency receives controlled substances from distributors.” 21 CFR 1300.06(b)(13).

✔️ Hospital-Based EMS Agencies May Use Hospital Registrations

Under the new regulatory provision 21 CFR 1301.20(a)(2), if an EMS agency is based at a DEA-registered hospital (and owned or operated by the hospital), it may use the hospital’s registration to administer controlled substances, without any need for it to obtain a separate EMS registration. To be clear, even before Congress passed the Act, DEA had historically allowed EMS agencies to operate under hospitals' registrations rather than separately registering, but it was never expressly authorized by regulation. Thus, this change memorializes an arrangement many hospitals already participated in.

Notwithstanding this allowance, now that EMS agencies have been given their own registration type, hospitals may want to consider whether to have their EMS agencies obtain their own separate registrations in order to operate their inventories separate from the hospital’s.  

✔️ Allowance for “Stationhouse” Deliveries

Under the new provision 21 CFR 1301.20(b), EMS agencies may now deliver controlled substances from a registered location to their unregistered designated stationhouses, so long as 30-day advance notice has been provided to DEA. The regulation defines “stationhouse” to mean “an enclosed structure within a state where the EMS agency is registered, which may house EMS vehicles at its premises, and which is actively and primarily being used by that EMS agency.” 21 CFR 1300.06(b)(16). This new definition removes the prior requirement that a stationhouse must house a vehicle inside and deletes “for emergency response,” acknowledging training, storage, and administrative uses. In short, this allowance gives EMS agencies the ability to move controlled substance inventory to their other facilities and store product at those facilities without having to separately register those locations. The new regulation confirms that these deliveries “shall not be treated as distribution.”

✔️ Specific Security Requirements

The Final Rule adds the new regulation 21 CFR 1301.80, which lists specific security measures that are unique to EMS agencies. This provision provides an exhaustive list of where controlled substances may be stored: at the registered location; at a designated stationhouse (following notice to DEA); in an EMS vehicle located at the registered location or designated stationhouse; or in an EMS vehicle while in transit to or returning from an emergency call. Additionally, the Final Rule adds specific locking requirements for EMS agencies’ vehicles, specific storage requirements (which includes an allowance for controlled substances to be stored in automated dispensing machines) and a limited allowance for EMS personnel to carry controlled substances “on their person or in a jump bag” during emergencies.

✔️ Expanded Authority for EMS Professionals

Under 21 CFR 1306.07(e), EMS professionals can now directly administer controlled substances without the medical director physically present, as long as state law allows and standing or verbal orders are in place. This change recognizes the realities of field medicine, where timely access to medications directly impacts patient outcomes. The Final Rule imposes specific recordkeeping requirements for such instances. See 21 CFR 1304.03(i). In order for an EMS professional to directly administer controlled substances, they must ensure they meet DEA’s definition of “Emergency medical services professional,” which is defined as “a health care professional (including a nurse, paramedic, or emergency medical technician) licensed or certified by the State in which the professional practices and credentialed by a medical director of the respective emergency medical services agency to provide emergency medical services within the scope of the professional's State license or certification.”

✔️ New Recordkeeping Requirements

Under 21 CFR 1304.27, EMS agencies now have very specific recordkeeping requirements that are unique to their activities, including: specific information that needs to be recorded for each dose that is administered, acquisition records and records for deliveries among an EMS agency’s locations.

The Final Rule takes effect March 9, 2026, so EMS agencies (and hospitals and practitioners engaged with them) should start preparing for compliance today, such as:

• Review current DEA registrations and determine whether consolidation is possible.

• Ensure protocols align with state laws governing controlled substance administration.

• Update policies for storage, transit, and documentation of controlled medications in line with the new regulations.

• Engage legal counsel to advise and guide you through this transition.